05.09.2025 - Procedure started

Note: Medicinal products containing levamisole are currently not available in Germany.

PRAC starts safety review of levamisole, a medicine used to treat parasitic worm infections
Review will assess risk of leukoencephalopathy, a condition affecting the brain

EMA’s safety committee (PRAC) has started a review of medicines containing levamisole, authorised in four countries of the European Union (EU) to treat infections caused by parasitic worms in adults and children.

Further Information

For details on the procedure please click on the following link to the homepage of the European Medicines Agency (EMA):